HUE071463T2 - Elnyújtott hatóanyag-leadású furazidinkészítmény - Google Patents
Elnyújtott hatóanyag-leadású furazidinkészítményInfo
- Publication number
- HUE071463T2 HUE071463T2 HUE21153203A HUE21153203A HUE071463T2 HU E071463 T2 HUE071463 T2 HU E071463T2 HU E21153203 A HUE21153203 A HU E21153203A HU E21153203 A HUE21153203 A HU E21153203A HU E071463 T2 HUE071463 T2 HU E071463T2
- Authority
- HU
- Hungary
- Prior art keywords
- furazidine
- extended
- release
- preparation
- release furazidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21153203.1A EP4032530B1 (fr) | 2021-01-25 | 2021-01-25 | Composition de furazidine à libération prolongée |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE071463T2 true HUE071463T2 (hu) | 2025-08-28 |
Family
ID=74236033
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE21153203A HUE071463T2 (hu) | 2021-01-25 | 2021-01-25 | Elnyújtott hatóanyag-leadású furazidinkészítmény |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP4032530B1 (fr) |
| DK (1) | DK4032530T3 (fr) |
| ES (1) | ES3030341T3 (fr) |
| FI (1) | FI4032530T3 (fr) |
| HR (1) | HRP20250564T1 (fr) |
| HU (1) | HUE071463T2 (fr) |
| LT (1) | LT4032530T (fr) |
| MA (1) | MA58128B1 (fr) |
| MD (1) | MD4032530T2 (fr) |
| PL (1) | PL4032530T3 (fr) |
| PT (1) | PT4032530T (fr) |
| RS (1) | RS66829B1 (fr) |
| SI (1) | SI4032530T1 (fr) |
| WO (1) | WO2022157357A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4545074A1 (fr) | 2023-10-27 | 2025-04-30 | Adamed Pharma S.A. | Composition pharmaceutique de furazidine pour administration vaginale |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3522929A2 (fr) * | 2016-10-10 | 2019-08-14 | Przedsiebiorstwo Produkcji Farmaceutycznej Hasco-Lek S.A. | Nouvelles compositions de furazidine et leurs procédés de préparation |
-
2021
- 2021-01-25 MA MA58128A patent/MA58128B1/fr unknown
- 2021-01-25 MD MDE20221166T patent/MD4032530T2/ro unknown
- 2021-01-25 ES ES21153203T patent/ES3030341T3/es active Active
- 2021-01-25 HU HUE21153203A patent/HUE071463T2/hu unknown
- 2021-01-25 HR HRP20250564TT patent/HRP20250564T1/hr unknown
- 2021-01-25 LT LTEP21153203.1T patent/LT4032530T/lt unknown
- 2021-01-25 PT PT211532031T patent/PT4032530T/pt unknown
- 2021-01-25 EP EP21153203.1A patent/EP4032530B1/fr active Active
- 2021-01-25 SI SI202130308T patent/SI4032530T1/sl unknown
- 2021-01-25 RS RS20250465A patent/RS66829B1/sr unknown
- 2021-01-25 FI FIEP21153203.1T patent/FI4032530T3/fi active
- 2021-01-25 DK DK21153203.1T patent/DK4032530T3/da active
- 2021-01-25 PL PL21153203.1T patent/PL4032530T3/pl unknown
-
2022
- 2022-01-24 EP EP22702430.4A patent/EP4281048A1/fr active Pending
- 2022-01-24 WO PCT/EP2022/051486 patent/WO2022157357A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP4281048A1 (fr) | 2023-11-29 |
| ES3030341T3 (en) | 2025-06-27 |
| WO2022157357A1 (fr) | 2022-07-28 |
| EP4032530B1 (fr) | 2025-04-09 |
| MA58128B1 (fr) | 2025-05-30 |
| MD4032530T2 (ro) | 2025-07-31 |
| PT4032530T (pt) | 2025-06-04 |
| RS66829B1 (sr) | 2025-06-30 |
| PL4032530T3 (pl) | 2025-06-16 |
| LT4032530T (lt) | 2025-05-26 |
| HRP20250564T1 (hr) | 2025-07-04 |
| DK4032530T3 (da) | 2025-05-19 |
| SI4032530T1 (sl) | 2025-06-30 |
| FI4032530T3 (fi) | 2025-05-27 |
| EP4032530A1 (fr) | 2022-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4582426A4 (fr) | Composé inhibiteur de pan-kras | |
| EP4610263A4 (fr) | Composé inhibiteur de pan-kras | |
| JP1780369S (ja) | ブレンダー | |
| EP4271380A4 (fr) | Formulations d'upadacitinib à libération prolongée | |
| EP4444734A4 (fr) | Conjugué d'acide biliaire | |
| HUE071463T2 (hu) | Elnyújtott hatóanyag-leadású furazidinkészítmény | |
| EP4320989A4 (fr) | Améliorations de mr-dc | |
| JP1775087S (ja) | ブレンダー | |
| CL2024000706S1 (es) | Licuadora | |
| CR20230339S (es) | Licuadora | |
| CR20230336S (es) | Licuadora | |
| CR20230340S (es) | Licuadora | |
| CR20230338S (es) | Licuadora | |
| CR20230337S (es) | Licuadora | |
| CR20230347S (es) | Batidora | |
| EP4516792A4 (fr) | Composé benzothiophène | |
| JP1708772S (ja) | 長いす | |
| JP1708760S (ja) | 長いす | |
| EP4176782A4 (fr) | Mélangeur | |
| EP4267809A4 (fr) | Raccord | |
| UA43803S (uk) | Блендер | |
| JP1705758S (ja) | 椅子 | |
| JP1704038S (ja) | 椅子 | |
| JP1704037S (ja) | 椅子 | |
| JP1704039S (ja) | 椅子 |